Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Cytology Predicts Infections in Pulmonary Lesions

By LabMedica International staff writers
Posted on 11 Nov 2010
The examination of pulmonary fine-needle aspiration biopsy specimens by a cytopathologist aids in identifying the infectious organisms in pulmonary lesions.

Fine-needle aspiration biopsy (FNAB) of the lung is an invasive procedure commonly used to evaluate localized lesions, and can be used in determining the diagnosis of infectious causes before bacterial cultures yield results.

In a retrospective study carried out at the University of California, San Francisco (UCSF; San Francisco, CA, USA), scientists reviewed 820 FNABs that were performed on patients with pulmonary nodules over a 10-year study period. All samples were sent for cytopathologic evaluation and 80 (10%) FNABs were also sent for microbiologic culture. There were 24 samples with positive culture results (30%) comprising 28 organisms with two samples yielding two organisms and one with three organisms isolated. Eighteen isolates were bacterial, five were fungal, and five were mycobacterial. Seventeen samples (21%) yielded organisms considered potentially clinically significant, whereas seven (9%) were likely contaminants.

Cytopathologic findings associated with infectious etiologies (inflammatory cells, necrotic debris, and/or microbial organisms) were seen in all but four culture-positive cases, and three of these yielded contaminant organisms. Using culture as the gold standard and excluding contaminant organisms, sensitivity and specificity of cytology were 94% and 43%, with positive and negative predictive values of 33% and 96%, respectively. Cytology predicted positive cultures in all cases where organisms were visualized, and it was associated with negative cultures in 24 of 25 cases where inflammatory changes and necrosis were absent.

The authors of the study concluded that cytological results are often available more rapidly than cultures, particularly for slowly growing organisms, and may be used to guide treatment decisions before definitive culture diagnosis. The study was published in November 2010 in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
University of California, San Francisco




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Troponin I Test
Quidel Triage Troponin I Test
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.